NIH halts arm of clinical trial evaluating a potential stroke treatment
Study found low-dose rivaroxaban to be unsafe and ineffective compared to standard of care....
Read MoreStudy found low-dose rivaroxaban to be unsafe and ineffective compared to standard of care....
Read MoreFEBRUARY 9, 2026 — A Mayo Clinic study is providing new insights into how treatment sequence can...
Read MoreFEBRUARY 10, 2026 – As Valentine’s Day approaches, a time often associated with love and...
Read MoreFirst-of-its-kind partnership will bring Cleveland Clinic’s innovative health and wellness...
Read MoreNet income available to common shareholders in fourth quarter 2025 was $371 million, or $4.22 per...
Read More